SpliceCore Description
Harnessing RNA sequencing (RNA-seq) data alongside Artificial Intelligence presents both a crucial necessity and a significant opportunity for creating therapies aimed at correcting splicing errors. By leveraging machine learning, we can uncover novel splicing errors and swiftly formulate therapeutic compounds to address them. Our AI platform, SpliceCore, is specifically designed for discovering RNA therapeutics. This cutting-edge technology focuses on analyzing RNA sequencing data with unparalleled efficiency. It can swiftly identify, evaluate, and validate potential drug targets, outpacing traditional methodologies. Central to SpliceCore is our unique repository containing over 5 million potential RNA splicing errors, making it the largest of its kind globally and instrumental for testing any RNA sequencing dataset submitted for analysis. The integration of scalable cloud computing allows us to handle vast quantities of RNA sequencing data in a way that is not only efficient but also cost-effective, significantly speeding up the pace of therapeutic advancements. This innovative approach promises to revolutionize the landscape of RNA therapeutics.
SpliceCore Alternatives
PathSolutions TotalView
TotalView offers network monitoring as well as root-cause troubleshooting of problems in plain-English. The solution monitors every device as well as every interface on every device. In addition, TotalView goes deep, collecting 19 error counters, performance, configuration, and connectedness so nothing is outside of it’s view. A built-in heuristics engine analyzes this information to produce plain-English answers to problems. Complex problems can now be solved by junior level engineers leaving the senior level engineers to work on more strategic level projects. The core product includes everything needed to run a perfectly healthy network: Configuration management, server monitoring, cloud service monitoring, IPAM, NetFlow, path mapping, and diagramming. Get Total Network Visibility on your network and solve more problems faster.
Learn more
Stack AI
AI agents that interact and answer questions with users and complete tasks using your data and APIs. AI that can answer questions, summarize and extract insights from any long document. Transfer styles and formats, as well as tags and summaries between documents and data sources. Stack AI is used by developer teams to automate customer service, process documents, qualify leads, and search libraries of data. With a single button, you can try multiple LLM architectures and prompts. Collect data, run fine-tuning tasks and build the optimal LLM to fit your product. We host your workflows in APIs, so that your users have access to AI instantly. Compare the fine-tuning services of different LLM providers.
Learn more
BioNeMo
BioNeMo is a cloud service and framework for drug discovery that leverages AI, built on NVIDIA NeMo Megatron, which enables the training and deployment of large-scale biomolecular transformer models. This service features pre-trained large language models (LLMs) and offers comprehensive support for standard file formats related to proteins, DNA, RNA, and chemistry, including data loaders for SMILES molecular structures and FASTA sequences for amino acids and nucleotides. Additionally, users can download the BioNeMo framework for use on their own systems. Among the tools provided are ESM-1 and ProtT5, both transformer-based protein language models that facilitate the generation of learned embeddings for predicting protein structures and properties. Furthermore, the BioNeMo service will include OpenFold, an advanced deep learning model designed for predicting the 3D structures of novel protein sequences, enhancing its utility for researchers in the field. This comprehensive offering positions BioNeMo as a pivotal resource in modern drug discovery efforts.
Learn more
BIOiSIM
BIOiSIMTM represents a groundbreaking 'virtual drug development engine' that significantly enhances the drug development sector by effectively identifying drug compounds that are most likely to provide meaningful therapeutic benefits for various diseases or conditions. We provide an array of translational solutions that are tailored to meet the specific needs of your pre-clinical and clinical initiatives. Central to our offerings is the highly validated BIOiSIMTM platform, which supports the development of small molecules, large molecules, and viruses. This innovative platform is underpinned by extensive data derived from thousands of compounds across seven different species, resulting in a level of robustness that is uncommon in the field. Emphasizing human health outcomes, the heart of the platform features a translatability engine that seamlessly converts insights gained from different species. Importantly, the BIOiSIMTM platform can be deployed prior to the initiation of preclinical animal trials, facilitating earlier insights and potentially reducing the costs associated with outsourced experimentation. By integrating these advanced capabilities, we aim to streamline the drug development process and accelerate the journey from discovery to market.
Learn more
Integrations
No Integrations at this time
Company Details
Company:
Envisagenics
Year Founded:
2014
Headquarters:
United States
Website:
www.envisagenics.com/platform/
Media
Recommended Products
Our Free Plans just got better! | Auth0
You asked, we delivered! Auth0 is excited to expand our Free and Paid plans to include more options so you can focus on building, deploying, and scaling applications without having to worry about your security. Auth0 now, thank yourself later.
Product Details
Platforms
Web-Based
Types of Training
Training Docs
In Person
Training Videos
Customer Support
Business Hours
Online Support
SpliceCore Features and Options
SpliceCore User Reviews
Write a Review- Previous
- Next